ScripA few months after restructuring to conserve cash and put primary focus on its lead candidate BDTX-1535 in first-line non-small cell lung cancer, Black Diamond Therapeutics found a lifeline in Servier
ScripThe number of biopharmaceutical companies that have gone public in the US in 2024 has now beat the 2023 total of 21 with the 10 October initial public offerings by Upstream Bio Inc. and CAMP4 Thera
In VivoCancer treatment has transformed over the last 25 years. Since the first genetically targeted treatments emerged in the 1990s and immune checkpoint inhibitors in the 2010s, oncology has consistently o
ScripApogee Therapeutics, Inc. and Sagimet Biosciences, Inc. saw nothing unlucky about launching their initial public offerings on the 13th day of July, marking the first big biopharmaceutical company I